Edward J. Zatta, RPh
Founder and Chief Executive Officer of RXQ Compounding, LLC
Ed has been involved in the pharmacy industry since 1988 when he graduated from Ohio Northern University. For the last 8 years, Ed has been developing four retail pharmacy stores in the Southeast Ohio and West Virginia. Ed has taken the sales of all of his pharmacies from 3.8 million dollars in 2007 to revenues of 15 million in 2015.
In the spring 2014, while attending an Ohio Pharmacist Association Meeting and listening to a presentation by attorney Lee Rosebush, Ed learned that many of the compounding practices his pharmacies currently conducted would soon be illegal based upon new FDA regulations requiring companies that compound medications to meet new licensing requirements under FDA Regulation Section 503B. It was at this lecture that Ed introduced himself to Lee. In striking up that conversation, Ed decided then and there to take on the new regulations and seized a burgeoning opportunity. He set up a new entity, a FDA Approved 503B Outsourcing Facility, and, thus, RXQ Compounding, LLC, was born. Lee collaborated with Ed and guided the development of RXQ. After forming the company in 2014, the facility went online and began compounding in RXQ’s clean rooms under the new FDA guidelines by July of 2015. Since January 2015, both the FDA and the Ohio State Board of Pharmacy have recognized RXQ Compounding, LLC, as a duly licensed 503B Outsourcing Facility in full compliance with all state and FDA licensing rules and regulations.
On a personal note, Ed and his wife, Jennifer, have three extremely active children, Alexis, 19, Lindsay, 18, and Ethan, 16. The Zatta family resides in the college town of Athens, Ohio and enjoy spending time together traveling, on the ski slopes, or just at home. Ed is also an extremely avid biker who, in 2014, road his bicycle on a cross country trip from Palm Springs, California to West Palm Beach Florida, as fund raiser for the “Paley Foundation.” This organization does limb lengthening surgeries for children and is a charity for which Ed has a great passion.
Chief Operating Officer
Tony Schwartz serves as Chief Operating Officer of RXQ Compounding, LLC and is responsible for the day-to-day leadership and general management of the company. In this role, Tony has helped to establish RXQ Compounding, LLC as premier Outsourcing Facility. Under his management, RXQ is consistently achieving year-over-year revenue, profitability, client and associate growth.
Over the last decade, Tony has held several senior leadership roles and led 503B Outsourcing Facilities in growing revenue, meeting regulatory requirements, expanding operations, and attracting talented associates. Prior to joining RXQ Compounding, LLC, Tony served as the General Manager, 503B Outsourcing Facility at Resource, Optimization, Innovation, LLC. Tony has also served as the Director of Business Development at Pharmakon Pharmaceuticals and has held various executive and management positions during his twenty years in the pharmaceutical industry.
Michael L. Miller, RPh MHA
Mike Miller serves as the Operations Manager at RXQ Compounding, LLC. He is a 1985 graduate of West Virginia University with a BS in Pharmacy and a 2012 graduate of New England College with a Masters of Science in Healthcare Administration. Mike has worked in several areas of Pharmacy – Retail, Long-Term care, Home Health, as well as, Hospital Pharmacy Management where he has been for the last 17 years.
Mike and his wife Carol, who is also a Pharmacist, reside in Washington, WV. They have three grown children: Adam in Columbia, MO, Amy Marie Constable who resides in Charleston, WV with her husband Drew and Christopher who lives in Washington as well. Mike joined the RXQ Compounding team in July 2018.
Quality Assurance Manager
David Leon officially joined RXQ Compounding, LLC in July of 2018. David received his Bachelor’s in Science with major in Chemistry from University of Puerto Rico at Mayaguez, PR and MBA with major in Management and minor in Marketing from Interamerican University at San German, PR. He has worked in pharmaceutical companies for more than 30 years with parenteral, oral products, API, and medical devices (IVD) in big, small and mid-size pharma.